Skip to main content

Animations

MJFF Publications

6851 - 6860 of 8808 Results
Title
Year
  • Year
  • 2023
  • 2021
  • 2025
  • 2023
  • 2020
  • 2019
  • 2022
  • 2016
  • 2024
  • 2015
  • Summary Details
    OPEN
    Title: Care access and utilization among medicare beneficiaries living with Parkinson’s disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-023-00523-y
    Citation Count: 23
  • Summary Details
    RESTRICTED
    Title: Evaluation of a Low-Toxicity PARP Inhibitor as a Neuroprotective Agent for Parkinson’s Disease
    Journal Name: Molecular Neurobiology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1007/s12035-021-02371-4
    Citation Count: 14
  • Summary Details
    OPEN
    Title: A blood-based DNA damage signature in patients with Parkinson’s disease is associated with disease progression
    Journal Name: Nature Aging
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s43587-025-00926-x
    Citation Count: 0
  • Summary Details
    OPEN
    Title: High-content phenotypic screen to identify small molecule enhancers of Parkin-dependent ubiquitination and mitophagy
    Journal Name: SLAS Discovery
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.slasd.2022.12.004
    Citation Count: 11
  • Summary Details
    OPEN
    Title: α-Synuclein-specific T cell reactivity is associated with preclinical and early Parkinson’s disease
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-020-15626-w
    Citation Count: 341
  • Summary Details
    OPEN
    Title: Age-dependent nigral dopaminergic neurodegeneration and α-synuclein accumulation in RGS6-deficient mice
    Journal Name: JCI Insight
    Publisher: American Society for Clinical Investigation
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1172/jci.insight.126769
    Citation Count: 22
  • Summary Details
    RESTRICTED
    Title: Deep learning architectures for Parkinson's disease detection by using multi-modal features
    Journal Name: Computers in Biology and Medicine
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.compbiomed.2022.105610
    Citation Count: 36
  • Summary Details
    OPEN
    Title: TRIM28 regulates the nuclear accumulation and toxicity of both alpha-synuclein and tau
    Journal Name: eLife
    Publisher: eLife Sciences Publications, Ltd
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.7554/elife.19809
    Citation Count: 122
  • Summary Details
    RESTRICTED
    Title: α-synuclein overexpression and the microbiome shape the gut and brain metabolome in mice
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-024-00816-w
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Arizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program
    Journal Name: Neuropathology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1111/neup.12189
    Citation Count: 427
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.